4-Methylmorpholine → HCID 59598286, compound

HRID 2265945Notes

Reaction equation

HRID 2265945 reaction equation
Cl.[F:2][C:3]1[CH:4]=[C:5]([CH:8]=[CH:9][C:10]=1[NH:11][S:12]([CH3:15])(=[O:14])=[O:13])[CH2:6][NH2:7].[C:16]([C:20]1[N:25]=[C:24]([Cl:26])[C:23]([O:27][CH2:28][C:29](O)=[O:30])=[CH:22][CH:21]=1)([CH3:19])([CH3:18])[CH3:17].CN1CCOCC1>C1COCC1>[C:16]([C:20]1[N:25]=[C:24]([Cl:26])[C:23]([O:27][CH2:28][C:29]([NH:7][CH2:6][C:5]2[CH:8]=[CH:9][C:10]([NH:11][S:12]([CH3:15])(=[O:14])=[O:13])=[C:3]([F:2])[CH:4]=2)=[O:30])=[CH:22][CH:21]=1)([CH3:19])([CH3:17])[CH3:18]

Participants

5

Reactant 3

HCID 79724-MethylmorpholineHCID 21097525N-[4-(aminomethyl)-2-fluorophenyl]methanesulfonamide hydrochlorideHCID 86625521HCID 86625521, compound

Product 1

HCID 59598286HCID 59598286, compoundYield 28.2%

Reagents, catalysts & solvents 1

HCID 8028TetrahydrofuranSolvent

Procedure

3-Fluoro-4-methanesulfonylaminobenzylamine hydrochloride (21 mg, 0.08 mmol) was reacted with (6-tert-butyl-2-chloro-pyridin-3-yloxy)-acetic acid (1.0 eq, 20 mg) DMTMM (1.2 eq, 27 mg) and NMM (1.5 eq, 14 μl) in THF to give the title compound (10 mg, 28.2%) after purification by column chromatography (Hex/EtOAc=1/1).

Sources & evidence

ORD record
ord-6bfa25a4e2f84781b0917b61eb30a530
Source dataset
uspto-grants-2010_12
Patent number
US07858621B2

Reaction notes

Loading…